Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Proks P, Reimann F, Green N, Gribble F, Ashcroft F
Beyond weight management, DA-1726 demonstrated notable improvements in non-invasive liver biomarkers, including significant reductions in liver stiffness, Controlled Attenuation Parameter (CAP) scores, and FibroScan-AST (FAST) scores
Approval timing is unknown and will depend on the results of these trials and subsequent regulatory review
it can invalidate the question the protocol was designed to answer
US$ 29.43
US$ 26.31
US$ 20.60
